Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
07/03/1991 | EP0434727A1 Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents |
07/03/1991 | EP0434722A1 New pentapeptide and a process for the preparation thereof |
07/03/1991 | EP0434718A1 Peptide compounds |
07/03/1991 | EP0425507A4 Compositions and methods for treating skin conditions and promoting wound healing |
07/03/1991 | EP0398925A4 Growth inhibiting agent and the use thereof |
07/03/1991 | CN1052678A 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors |
07/03/1991 | CN1052659A Fluoro-naphthacenediones, their glycosilated derivatives and their manufacture procedures |
07/02/1991 | US5028727 Platinum-(IV)-diamine complex |
07/02/1991 | US5028698 Cytorhodin S derivatives and a process for their preparation |
07/02/1991 | US5028697 Antitumor agents, cell specific |
07/02/1991 | US5028626 Peptides with pharmaceutical activity |
07/02/1991 | US5028621 Drugs comprising porphyrins |
07/02/1991 | US5028593 Tuftsin analogs |
07/02/1991 | US5028536 Antitumor antibiotic BMY-41339 |
07/02/1991 | US5028420 Muteins of tumor necrosis factor |
07/02/1991 | CA1285562C Quinone derivatives, their production and use |
07/02/1991 | CA1285560C Derivatives of guanine |
07/02/1991 | CA1285507C Hybrid interferons |
07/02/1991 | CA1285479C Immunostimulant agents |
06/29/1991 | WO1991009875A1 Monoclonal antibody, hybridomas, their production and use |
06/29/1991 | CA2069872A1 Monoclonal antibody, hybridomas, their production and use |
06/28/1991 | CA2032974A1 Process for the preparation of glycosylanthracyclinones |
06/28/1991 | CA2032972A1 Benzanthracene compound and a process for preparing the same |
06/27/1991 | WO1991009124A1 Variants of pai-2 |
06/27/1991 | WO1991009057A1 Novel proteins with oncostatin m activity and process for their preparation |
06/27/1991 | WO1991009046A1 Morpholinyl derivatives of doxorubicin and process for their preparation |
06/27/1991 | WO1991008770A1 Method for antibody targeting of diagnostic or therapeutic agents |
06/27/1991 | WO1991008743A1 Circumvention of human tumor drug resistance |
06/27/1991 | DE3942280A1 N-substituierte naphthalimide, ihre herstellung und verwendung N-substituted naphthalimides, their preparation and use |
06/27/1991 | CA2070171A1 Proteins with oncostatin m activity and process for their preparation |
06/27/1991 | CA2045601A1 Circumvention of human tumor drug resistance |
06/26/1991 | WO1991009612A1 Tumor cell growth inhibitor |
06/26/1991 | EP0434571A2 New steroid derivatives with a substituted ethyl group on the position 10, process for their production, the use as a medicine of one of these compounds and pharmaceutical compositions containing it. |
06/26/1991 | EP0434445A2 Process to obtain new mixed copper aminoacidate complexes from phenanthrolines and their alkyl derivatives to be used as anticancerigenic agents |
06/26/1991 | EP0434444A1 Process to obtain new mixed copper aminoacidate complexes from phenylate Phenathrolines to be used as anticancerigenic agents |
06/26/1991 | EP0434057A2 Indolocarbazole derivatives, processes for their preparation and their use |
06/26/1991 | EP0434020A1 2,19-Methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors |
06/26/1991 | EP0433827A2 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
06/26/1991 | EP0433765A1 The use of immunomodulants as synergistic agents of chemotherapeutics in tumor therapy |
06/26/1991 | EP0433744A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration |
06/26/1991 | EP0433683A2 Use of benzothiazepines as potentiators of anti-cancer drugs |
06/26/1991 | EP0433682A2 Use of 2,4,5-tri(4-methoxyphenyl)-4,5-dihydroimidazole for the treatment of cancer |
06/26/1991 | EP0433678A1 Alkoxymethylidene epipodophyllotoxin glucosides |
06/26/1991 | EP0433442A1 Hybrid molecules |
06/26/1991 | EP0433360A1 Improvements relating to the production of prodrugs. |
06/26/1991 | CN1012957B Process for preparation of quinoline derivatives |
06/26/1991 | CA2044621A1 Inhibiting agent against the proliferation of tumour cells |
06/25/1991 | US5026882 Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase |
06/25/1991 | US5026836 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides, pharmaceutical compositions, and processes of making |
06/25/1991 | US5026826 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use |
06/25/1991 | CA1285287C Cycloalkyl-substituted-4-aminophenyl derivatives and process for their preparation |
06/23/1991 | CA2572802A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
06/22/1991 | WO1991009965A1 An improved toxin for construction of immunotoxins |
06/22/1991 | WO1991009850A1 N-substituted naphthalamides, their production and use |
06/22/1991 | CA2071946A1 Toxin for construction of immunotoxins |
06/22/1991 | CA2066457A1 N-substituted naphthalimides, their preparation and use |
06/21/1991 | WO1991009048A1 Boronated nucleosides |
06/21/1991 | WO1991009033A1 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
06/21/1991 | CA2071936A1 Boronated nucleosides |
06/19/1991 | EP0433225A1 Process for the production of biologically active protein (e.g. TGF) |
06/19/1991 | EP0432983A2 Novel compounds of the diterpene type |
06/19/1991 | EP0432697A2 BU-4146T antibiotic |
06/19/1991 | EP0432677A1 N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives |
06/19/1991 | EP0432630A2 Antitumor agent |
06/19/1991 | EP0432209A1 Phenylpyrrolic compounds used as drugs, their preparation and application. |
06/19/1991 | EP0248047B1 Medicament with anti-tumoral action containing hexadecylphosphocholine |
06/18/1991 | US5024835 Conjugates of a vinca derivative carrying a detergent chain in the C-3 position |
06/16/1991 | CA2032212A1 Compounds of the diterpene type |
06/15/1991 | CA2031394A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration |
06/14/1991 | WO1991008739A1 Growth arrest of proliferating cells by transglutaminase inhibitors |
06/14/1991 | CA2071550A1 Growth arrest of proliferating cells by transglutaminase inhibitors |
06/14/1991 | CA2032092A1 Antitumor agent |
06/13/1991 | WO1991008215A1 Process for the preparation of 2-amino-9-(2,3,5-tri-0-benzyl-beta-d-arabinofuranosyl)adenine and novel intermediates |
06/13/1991 | WO1991008214A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
06/13/1991 | WO1991008191A1 Novel potent inducers of terminal differentiation and method of use thereof |
06/13/1991 | WO1991007953A1 Tumour necrosis factor antagonist |
06/13/1991 | WO1991002062A3 C-erbb-2 external domain: gp75 |
06/12/1991 | EP0431799A2 Use of nucleoside derivatives as cytotoxic agents |
06/12/1991 | EP0431323A1 Antitumor antibiotic BU-3983T |
06/12/1991 | EP0431008A1 Mitomycin derivatives having reduced bone marrow toxicity, processes for their preparation, and the uses thereof |
06/12/1991 | CN1012815B Process for preparing gem-dihalo and tetrahalo-1,12-diamino-4,9-diaza-dodecanes |
06/12/1991 | CA2031650A1 Bu-4146t antibiotic |
06/11/1991 | US5023341 Acetylene thiochroman |
06/11/1991 | US5023340 Glycosidase inhibitors |
06/11/1991 | US5023335 1,2-bis (aminomethyl) cyclobutane-platinum complexes |
06/11/1991 | US5023254 Administering antiestrogens |
06/11/1991 | US5023184 Antibiotics from myxococcus |
06/06/1991 | DE3939372A1 Mitonafide-infusionsloesung Mitonafide-infusion spoon |
06/05/1991 | EP0430538A1 Isolation and structural elucidation of the cyclic peptide hymenistatin 1 |
06/05/1991 | EP0430193A1 Monoclonal antibodies and their use |
06/05/1991 | EP0430036A2 Benzothiazepine metastasis treatment |
06/05/1991 | EP0429585A1 Cytochalasin compositions and therapeutic methods |
06/05/1991 | EP0429454A1 Improvements relating to the control of neoplastic tissue growth |
06/05/1991 | CN1051937A Stem cell factor |
06/05/1991 | CN1051914A Peptides |
06/05/1991 | CN1051907A 24-homo-vitamin-0-derivatives, process for preparing them, pharmaceutical preparation containing them and use as pharmaceuticals |
06/05/1991 | CN1012732B Gen-dihalo-1, 8-diamino-4-aza-octanes |
06/04/1991 | US5021434 N-substituted imidazoles, as well as their use in pharmaceutical agents |
06/04/1991 | US5021423 Antibiotic, antitumor agent |
06/04/1991 | US5021235 Reducing and complexing radioactive perrhenates with bone seeking ligands |